Skip to main content
XXII
NASDAQ Manufacturing

22nd Century Group Reports Preliminary FY25 Results; Shareholders Approve Reverse Split & Future Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Neutral
Importance info
8
Price
$5.69
Mkt Cap
$2.903M
52W Low
$5.18
52W High
$1,138.5
52W Position info
9.8% above low
Off High info
100% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

XXII is trading near its 52-week low of $5.18 (9.8% above the low).

Summary

22nd Century Group reported preliminary Q4 and full-year 2025 results, highlighting a strong cash position and zero debt. Shareholders also approved a reverse stock split and authorizations for potentially dilutive future capital raises.


Key Events · Financing and Capital Events · XXII

  • Preliminary Q4 & FY 2025 Financial Results Released

    The company reported preliminary Q4 2025 net revenues of $3.6 million and full-year 2025 net revenues of $17.6 million. Operating loss improved to $2.8 million in Q4 and $11.6 million for the full year. Crucially, the company ended 2025 with $7.1 million in cash and zero long-term debt, significantly strengthening its balance sheet.

  • Shareholders Approve Reverse Stock Split

    Shareholders approved an amendment to effect a reverse stock split at a ratio between 1-for-2 and 1-for-200, at the Board's discretion, to comply with Nasdaq Listing Rules. This follows the company's announcement on January 22, 2026, of its intent to implement a reverse split.

  • Authorizations for Future Dilution Approved

    Shareholders approved proposals allowing the issuance of Series A Convertible Preferred Stock below the Nasdaq Minimum Price and authorizing a potential future offering. These approvals provide the company with mechanisms for future capital raises, which could lead to significant dilution for existing shareholders.


Analysis · XXII · Manufacturing

This filing presents a mixed but highly significant picture for 22nd Century Group. On one hand, the company has substantially improved its financial footing, ending 2025 with $7.1 million in cash and, critically, zero long-term debt. This provides a vital lifeline and runway for a micro-cap company, especially following a strategic shift to exit unprofitable revenue streams, which is reflected in improved operating and net losses despite a revenue decline. This financial stability is a strong positive signal for near-term survival.

However, shareholders also approved several measures that signal significant potential future dilution. The approval of a reverse stock split (between 1-for-2 and 1-for-200) is a necessary step to maintain NASDAQ listing but generally reflects a struggling stock price. More concerning are the approvals to issue Series A Convertible Preferred Stock below the Nasdaq Minimum Price and for a potential future offering. These authorizations grant the company flexibility to raise capital, but at the risk of substantial dilution to existing shareholders. Investors should weigh the improved balance sheet and liquidity against the clear path for future dilutive capital raises.

At the time of this filing, XXII was trading at $5.69 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $5.18 to $1,138.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Jul 02, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.01
Real-time Price: $4.23 info
Change: +$0.220 (+5%) info
Market Cap: $1.556M info
XXII
Jun 26, 2026, 4:15 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $3.93
Real-time Price: $4.23 info
Change: +$0.300 (+8%) info
Market Cap: $1.556M info
XXII
Jun 23, 2026, 5:23 PM EDT
Filing Type: DEF 14A
Importance Score:
10
Price at Filing: $4.70
Real-time Price: $4.23 info
Change: -$0.470 (-10%) info
Market Cap: $1.556M info
XXII
Jun 12, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $6.52
Real-time Price: $4.23 info
Change: Reverse Stock Split info
Market Cap: $1.556M info
XXII
Jun 12, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $6.51
Real-time Price: $4.23 info
Change: Reverse Stock Split info
Market Cap: $1.556M info